However, while hemoconcentration artificially raises cTnT levels in low-flux HD, in the clinical setting of suspected ongoing myocardial ischemia, adjusting for hemoconcentration will not be feasible and there are no data on whether this will alter test characteristics. This evidence concerns the gene TNNT2 and myocardial ischemia.